Focus on Polypharmacy in schizophrenia: does anyone truly benefit?
Open Access
- 1 January 1999
- journal article
- editorial
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 7 (2) , 109-111
- https://doi.org/10.1017/s1461145704004183
Abstract
Dr Suzuki and colleagues (Suzuki et al., 2004) are to be commended for their contribution of a novel, systematic study of polypharmacy in schizophrenia – a surprisingly under-studied topic given its high prevalence worldwide. We find their results quite informative and agree with their thoughtful and very balanced discussion of their results.Keywords
This publication has 0 references indexed in Scilit: